ClearanceBrief
Company · US

Bausch and Lomb, Incorporated

FDA 510(k) clearances and medical device recalls filed under this name, 2016 to 2026. Name variants (Inc, Corp, punctuation) are merged.

6510(k) clearances (2 in 12 months)
2recalls (0 in 12 months)
0recalls that name a 510(k)

Product codes

CodeDeviceRecords
HQCUnit, Phacofragmentation4
HMXCannula, Ophthalmic1
MRCProducts, Contact Lens Care, Rigid Gas Permeable1
MSSFolders And Injectors, Intraocular Lens (Iol)1
NAALens, Intraocular, Accommodative1

Latest 510(k) clearances

Decided510(k)Device and applicantCode
May 15, 2026K261264Stellaris Elite™ vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite™ Pack (SE54
Bausch and Lomb
HQC
Mar 25, 2026K252052Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E)
Bausch and Lomb, Incorporated
HQC
Jul 26, 2024K240169Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)
Bausch and Lomb, Incorporated
HQC
Feb 26, 2024K232084Stellaris Elite vision enhancement system
Bausch and Lomb
HQC
Mar 27, 2018K180319Bausch + Lomb Boston Advance Cleaner, Bausch + Lomb Boston Advance Conditioning Solution
Bausch and Lomb, Incorporated
MRC
Jul 6, 2016K161012Easy-Load Lens Delivery System
Bausch and Lomb, Inc.,
MSS

Latest recalls

DateFirm and productCodeLinked 510(k)
Jan 17, 2013Bausch and Lomb, Incorporated
Bausch and Lomb 27G sterile cannula packed in the Bausch and Lomb Amvisc 1.2% Sodium Hyaluronate ( Model 59051, 59081, 59051L, 59081L) and Amvisc Plus 1.6% Sodium Hyaluronate (Model 60081, 60051, 6005
Terminated
HMXNone listed
Jan 11, 2012Bausch and Lomb, Incorporated
Crystalens Accommodating Posterior Chamber Intraocular Lens, AT-50AO. Crystalens Accommodating Posterior Chamber Intraocular Lens PMA No.: P030002. The Crystalens is intended for primary implantatio
Terminated
NAANone listed
Get alerts for these product codes